Co-DiagnosticsAktie

 
11,890
 
USD
27.11.20 Nasdaq
-2,06 %
-0,250 USD
Geldkurs 27.11.20
11,840 USD
2.700 Stk.
Briefkurs 27.11.20
11,890 USD
1.700 Stk.
Mehr Daten anzeigen
Smartbroker
NewsFlashAnzeige
TAAT Lifestyle News: Irre!!! - Händler aus anderen Staaten "betteln" um die tabaklose Zigarette!

Co-Diagnostics Chart

Neuigkeiten zur Co-Diagnostics Inc Aktie

ZeitTitel
SmartbrokerSmartbroker: Ab 0€ pro Order handeln mit dem Testsieger (Finanztest 11/2020) Anzeige
26.11.20
Diskussion: Co-Diagnostics Completes Submission of CE Marking Registration for COVID-19 Coronavirus Test
Avatar bernd1980 schrieb:
Ja, wird Zeit. So richtig aber erst am Montag. Heute haben die Amis Thanksgiving und …
14.08.20
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Co-Diagnostics, Inc. (CODX)
12.08.20
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm
22.07.20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Co-Diagnostics, Inc. Investors of Important Deadline in Securities Class Action – CODX
06.07.20
Notice of Lead Plaintiff Deadline for Shareholders in the Co-Diagnostics, Inc. Class Action Lawsuit
30.06.20
CODX INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm Before August 17
27.06.20
CODX LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Reminds Co-Diagnostics, Inc. Investors of Important Deadline in Securities Class Action – CODX
26.06.20
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Co-Diagnostics, Inc. (CODX)
26.06.20
CODX SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm
24.06.20
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Co-Diagnostics, Inc. (CODX)
23.06.20
CODX INVESTOR ALERT: Kirby McInerney LLP Announces That a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm Before August 17
19.06.20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Co-Diagnostics, Inc. Investors (CODX)
19.06.20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Co-Diagnostics, Inc. (CODX) Investors
18.06.20
CO-DIAGNOSTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm
Insidertrade: :

Aktuelle Beiträge zur Co-Diagnostics Aktie

Aktienkurs Co-Diagnostics A2DU6V |

BörsenplatzNasdaq
Letzter Kurs11,890USD
Performance-2,06 %
Kurszeit27.11.20
Eröffnung12,140USD
Tageshoch12,170USD
Tagestief11,600USD
Vortageskurs12,140USD
Volumen1,53 Mio.Stk.
52-Wochen Hoch30,99USD
52-Wochen Tief0,870USD
Anzahl Trades4.404
Performance 1 Monat-13,53 %
Performance 1 Jahr+1.279,55 %

Stammdaten zu Co-Diagnostics

NameCo-Diagnostics Inc
KurznameCo-Diagnostics
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA2DU6V
SymbolCODX
BrancheBiotechnologie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl28,27 Mio.
Marktkapitalisierung336,12 Mio.USD

Performance Co-Diagnostics Aktie

ZeitKursPerf.
1 Tag11,890USD
-2,06 %
1 Woche10,870USD
+11,68 %
1 Monat14,040USD
-13,53 %
3 Monate13,155USD
-7,72 %
6 Monate18,030USD
-32,67 %
Lfd. Jahr0,895USD
+1.256,12 %
1 Jahr0,880USD
+1.279,55 %
3 Jahre5,100USD
+138,04 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameCo-Diagnostics Inc
StadtSalt Lake City, UT
LandUSA USA
Webseitewww.codiagnostics.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Bayer
+0,62
2.
Gilead Sciences
+0,89
3.
Illumina
+4,29
4.
NanoRepro
-1,21
5.
Inovio Pharmaceuticals
+18,00
6.
Shop Apotheke Europe
+1,22
7.
iBio
+4,11
8.
Moderna
+16,35
9.
Novavax
+22,50
10.
BioNTech
+4,79

Emissionsinformationen

Emissionspreis6,000USD
Emissionsvolumen1.300.000Stück
ZeichnungsgebührNein
IPO Anmeldetag28.04.2017
IPO12.07.2017
PlatzierungÖffentlich